Concert Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
17.40
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
2
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-12-31
|
-0.59
|
0.00
|
0.59
|
100.00%
|
|
2022-09-30
|
-0.59
|
-0.58
|
0.01
|
1.69%
|
|
2022-06-30
|
-0.85
|
-0.59
|
0.26
|
30.59%
|
|
2022-03-31
|
-0.91
|
-1.03
|
-0.12
|
-13.19%
|
|
2021-12-31
|
-0.73
|
-1.01
|
-0.28
|
-38.36%
|
|
2021-09-30
|
-0.81
|
-0.78
|
0.03
|
3.70%
|
|
2021-06-30
|
-0.74
|
0.16
|
0.90
|
121.62%
|
|
2021-03-31
|
-0.69
|
-0.67
|
0.02
|
2.90%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.20
|
|
2021-12-31
|
-2.30
|
|
2020-12-31
|
-2.40
|
|
2019-12-31
|
-3.29
|
|
2018-12-31
|
-2.39
|
|
2017-12-31
|
4.00
|
|
2016-12-31
|
-2.28
|
|
2015-12-31
|
0.96
|
|
2014-12-31
|
-2.00
|
|
2013-12-31
|
-4.64
|